GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Cash Flow from Operations

Chemical Works of Gedeon Richter (BUD:RICHTER) Cash Flow from Operations : Ft123,670 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2023, Chemical Works of Gedeon Richter's Net Income From Continuing Operations was Ft41,291 Mil. Its Depreciation, Depletion and Amortization was Ft14,104 Mil. Its Change In Working Capital was Ft-32,998 Mil. Its cash flow from deferred tax was Ft0 Mil. Its Cash from Discontinued Operating Activities was Ft0 Mil. Its Asset Impairment Charge was Ft0 Mil. Its Stock Based Compensation was Ft0 Mil. And its Cash Flow from Others was Ft6,499 Mil. In all, Chemical Works of Gedeon Richter's Cash Flow from Operations for the three months ended in Dec. 2023 was Ft28,896 Mil.


Chemical Works of Gedeon Richter Cash Flow from Operations Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Cash Flow from Operations Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98,214.00 133,520.00 139,904.00 185,996.00 123,670.00

Chemical Works of Gedeon Richter Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52,133.00 19,055.00 32,500.00 43,219.00 28,896.00

Chemical Works of Gedeon Richter Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Chemical Works of Gedeon Richter's Cash Flow from Operations for the fiscal year that ended in Dec. 2023 is calculated as:

Chemical Works of Gedeon Richter's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft123,670 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter  (BUD:RICHTER) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Chemical Works of Gedeon Richter's net income from continuing operations for the three months ended in Dec. 2023 was Ft41,291 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Chemical Works of Gedeon Richter's depreciation, depletion and amortization for the three months ended in Dec. 2023 was Ft14,104 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Chemical Works of Gedeon Richter's change in working capital for the three months ended in Dec. 2023 was Ft-32,998 Mil. It means Chemical Works of Gedeon Richter's working capital declined by Ft32,998 Mil from Sep. 2023 to Dec. 2023 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Chemical Works of Gedeon Richter's cash flow from deferred tax for the three months ended in Dec. 2023 was Ft0 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Chemical Works of Gedeon Richter's cash from discontinued operating Activities for the three months ended in Dec. 2023 was Ft0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Chemical Works of Gedeon Richter's asset impairment charge for the three months ended in Dec. 2023 was Ft0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Chemical Works of Gedeon Richter's stock based compensation for the three months ended in Dec. 2023 was Ft0 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Chemical Works of Gedeon Richter's cash flow from others for the three months ended in Dec. 2023 was Ft6,499 Mil.


Chemical Works of Gedeon Richter Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines